Drug Trial Radar · NCT00435591
A Study of Multiple Dosing Regimens of IV Conivaptan in Subjects With Euvolemic or Hypervolemic Hyponatremia
Last checked: Nov 19, 2026Latest source record: May 15, 2014 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
121
Actual
Start
Jan 2007
Primary completion
Sep 2008
Study completion Sep 2008
Sponsor
- Lead sponsor
- Cumberland PharmaceuticalsIndustry
- Sponsor type
- Industry
- First posted
- Feb 15, 2007
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The study will evaluate the effectiveness and safety of multiple dosing regimens of IV conivaptan in subjects with euvolemic or hypervolemic hyponatremia
Conditions
- Hyponatremia
- Euvolemia
- Hypervolemia
Interventions
ConivaptanDrug
ampoule or premix bag
placeboDrug
ampoule or premix bag
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number and Severity of Infusion Site Reactions (ISRs) Using a Modified ISR Reporting Scale for Phlebitis and Infiltration in Patients Treated With Dose Regimen 1 and Dose Regimen 2Time frame: 48 hours
Locations
18 sites in 3 countries. Site status is shown where the registry gives one.
Site not named
Charleston, South Carolina
Site not named
Bangalore, India
Site not named
Bangalore, India
Site not named
Bhopal, India
Site not named
Hyderabaad, India
Site not named
Karnāl, India
Site not named
Afula, Israel
Site not named
Ashkelon, Israel
Site not named
Haifa, Israel
Site not named
Haifa, Israel
Site not named
Holon, Israel
Site not named
Jerusalem, Israel
Site not named
Jerusalem, Israel
Site not named
Rehovot, Israel
Site not named
Safed, Israel
Site not named
Tel Aviv, Israel
Site not named
Tel HaShomer, Israel
Site not named
Tsrifin, Israel
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.